The Study of the Decade Results are In!


Duke Medicine has found that using a combination of chemicals and UV light to clean patient rooms cut transmission of four major superbugs by a cumulative 30 percent among a specific group of patients!


Tru-D’s method of measured reflective dose and its impact on infection reduction has been proven!

Enhanced terminal room disinfection strategies that utilized Tru-D SmartUVC reduced the risk of acquisition and infection caused by target multi-drug resistant organisms by greater than 30 percent (Daniel J. Sexton, MD, et al., 2015).

These reduction rates, validated through the first and only randomized clinical trial of its kind, differentiate Tru-D from all other devices on the market.

Read the Abstract

The BETR-D Abstract Presented

The long awaited BETR-D abstract, Benefits of Enhanced Terminal Disinfection and a Duke Medicine news article have been released.



See the Latest from Duke